compound libraries

Every company has compound collections of different sizes, but we all face the same challenge of the rising cost of R&D. - Ludovic Otterbein Ludovic Otterbein, Head of Global Compound Man...

High-throughput screening (HTS) has developed into a hugely important and valuable area for the pharmaceutical industry, particularly in the field of drug discovery. The method has the potential...

For many organisations in the pharmaceutical sector, the area of compound management can be a problematic one due to all the potential complexities involved. Simplifying this process is high on t...

An efficient and versatile compound management operation is essential for the success of all downstream processes in high throughput screening (HTS) and small molecule development.  The 6th Comp...

In this exclusive interview, Dr. Sylviane Boucharens, Section Head of Molecular Pharmacology Department at MSD, speaks to Andrea Charles from Pharma IQ, about the current hurdles to accurate...

Dr. Steffen Renner, Investigator II, Molecular and Library Informatics at Novartis Pharma AG, speaks to Andrea Charles from Pharma IQ, about the current challenges relating to compound storage an...

Dr. Andy Bell, Research Fellow at Sandwich Laboratories Worldwide R&D, Pfizer, shares his insights on Pfizer's review of their screening file, prior to the merger with Wy...

Pharma IQ spoke with Konrad Koehler, Principal Scientist at  Karo Bio about the exploitation of privileged structures in the design of nuclear receptor targeted libraries. Pharma IQ: What&rsq...

Urs Lüthi, Senior Lab Head HTS Compound Management Actelion Pharmaceuticals Ltd., presents his company’s stance on innovative processes and maintenance of  library compounds. Read th...